277 related articles for article (PubMed ID: 2566675)
1. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.
Silver PJ; O'Connor B; Cumiskey WR; Van Aller G; Hamel LT; Bentley RG; Pagani ED
J Pharmacol Exp Ther; 1991 Apr; 257(1):382-91. PubMed ID: 1850474
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
7. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
[TBL] [Abstract][Full Text] [Related]
8. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats.
Papapetropoulos A; Marczin N; Snead MD; Cheng C; Milici A; Catravas JD
Hypertension; 1994 Apr; 23(4):476-84. PubMed ID: 7511569
[TBL] [Abstract][Full Text] [Related]
12. Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle.
Nakahara T; Yunoki M; Moriuchi H; Mitani A; Sakamoto K; Ishii K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):262-9. PubMed ID: 12172709
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
Park K; Moreland RB; Goldstein I; Atala A; Traish A
Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
[TBL] [Abstract][Full Text] [Related]
14. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of low Km cyclic GMP phosphodiesterases and potentiation of guanylate cyclase activators by cicletanine.
Silver PJ; Buchholz A; Dundore RL; Harris AL; Pagani ED
J Cardiovasc Pharmacol; 1990 Sep; 16(3):501-5. PubMed ID: 1700224
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
18. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
Torphy TJ; Undem BJ; Cieslinski LB; Luttmann MA; Reeves ML; Hay DW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]